CoChat
Sign Up
Cited by 51

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Selected recent advances in understanding the role of human mast cells in health and disease

Levi-Schaffer, Francesca, Gibbs, Bernhard F., Hallgren, Jenny, Pucillo, Carlo, Redegeld, Frank, Siebenhaar, Frank, Vitte, Joana, Mezouar, Soraya, Michel, Moïse, Puzzovio, Pier Giorgio, Maurer, Marcus·2022·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2022.01.030
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2022.01.030

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 128

  1. Church, 1997, The human mast cell, J Allergy Clin Immunol, 99, 155, 10.1016/S0091-6749(97)70089-7 · DOI
  2. Kaliner, 1979, The mast cell—a fascinating riddle, N Engl J Med, 301, 498, 10.1056/NEJM197908303010910 · DOI
  3. Riley, 1954, The riddle of the mast cells a tribute to Paul Ehrlich, Lancet, 263, 841, 10.1016/S0140-6736(54)91417-8 · DOI
  4. Fujisawa, 2014, Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria, J Allergy Clin Immunol, 134, 622, 10.1016/j.jaci.2014.05.004 · DOI
  5. Andersson, 2009, Novel site-specific mast cell subpopulations in the human lung, Thorax, 64, 297, 10.1136/thx.2008.101683 · DOI
  6. Motakis, 2014, Redefinition of the human mast cell transcriptome by deep-CAGE sequencing, Blood, 123, e58, 10.1182/blood-2013-02-483792 · DOI
  7. Dwyer, 2016, Expression profiling of constitutive mast cells reveals a unique identity within the immune system, Nat Immunol, 17, 878, 10.1038/ni.3445 · DOI
  8. Plum, 2020, Human mast cell proteome reveals unique lineage, putative functions, and structural basis for cell ablation, Immunity, 52, 404, 10.1016/j.immuni.2020.01.012 · DOI
  9. Cildir, 2019, Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases, Immunity, 51, 949, 10.1016/j.immuni.2019.09.021 · DOI
  10. Dwyer, 2021, Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation, Sci Immunol, 6, 10.1126/sciimmunol.abb7221 · DOI · Paper page
  11. Holt, 2000, The development of the immune system during pregnancy and early life, Allergy, 55, 688, 10.1034/j.1398-9995.2000.00118.x · DOI
  12. Omi, 1991, Human fetal mast cells under development of the skin and airways, Allergy, 40, 1407
  13. Schuster, 2012, Phenotypic characterization of leukocytes in prenatal human dermis, J Investig Dermatol, 132, 2581, 10.1038/jid.2012.187 · DOI
  14. Msallam, 2020, Fetal mast cells mediate postnatal allergic responses dependent on maternal IgE, Science, 370, 941, 10.1126/science.aba0864 · DOI · Paper page
  15. Kirshenbaum, 1999, Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13), Blood, 94, 2333, 10.1182/blood.V94.7.2333.419k30_2333_2342 · DOI
  16. Kirshenbaum, 1991, Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells, J Immunol, 146, 1410, 10.4049/jimmunol.146.5.1410 · DOI · Paper page
  17. Dahlin, 2016, Lin− CD34hi CD117Int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors, Blood, 127, 383, 10.1182/blood-2015-06-650648 · DOI
  18. Salomonsson, 2020, Demonstration of human mast cell progenitors in the bone marrow, Allergy, 75, 456, 10.1111/all.14004 · DOI
  19. Dahlin, 2017, KIT signaling is dispensable for human mast cell progenitor development, Blood, 130, 1785, 10.1182/blood-2017-03-773374 · DOI
  20. Drissen, 2019, Identification of two distinct pathways of human myelopoiesis, Sci Immunol, 4, 7148, 10.1126/sciimmunol.aau7148 · DOI
  21. Grootens, 2020, CD203c distinguishes the erythroid and mast cell-basophil differentiation trajectories among human FcεRI+ bone marrow progenitors, Allergy, 75, 211, 10.1111/all.13981 · DOI
  22. Méndez-Enríquez E, Salomonsson M, Eriksson J, Janson C, Malinovschi A, Sellin ME, et al. IgE cross-linking induces activation of human and mouse mast cell progenitors [published online ahead of print September 4, 2021]. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2021.08.019. · DOI
  23. Falduto, 2021, Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications, Pharmacol Therapeut, 220, 10.1016/j.pharmthera.2020.107718 · DOI
  24. Redegeld, 2018, Non-IgE mediated mast cell activation, Immunol Rev, 282, 87, 10.1111/imr.12629 · DOI
  25. Yu, 2016, Non-IgE mediated mast cell activation, Eur J Pharmacol, 778, 33, 10.1016/j.ejphar.2015.07.017 · DOI
  26. McNeil, 2015, Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions, Nature, 519, 237, 10.1038/nature14022 · DOI · Paper page
  27. Subramanian, 2016, Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases, J Allergy Clin Immunol, 138, 700, 10.1016/j.jaci.2016.04.051 · DOI
  28. Kühn, 2021, Mas-related G protein–coupled receptor X2 and its activators in dermatologic allergies, J Allergy Clin Immunol, 147, 456, 10.1016/j.jaci.2020.08.027 · DOI
  29. Thapaliya, 2021, Mast cell-specific MRGPRX2: a key modulator of neuro-immune interaction in allergic diseases, Curr Allergy Asthma Rep, 21, 3, 10.1007/s11882-020-00979-5 · DOI
  30. Babina, 2017, Retinoic acid negatively impacts proliferation and MCTC specific attributes of human skin derived mast cells, but reinforces allergic stimulability, Int J Mol Sci, 18, 525, 10.3390/ijms18030525 · DOI
  31. Naranjo, 2020, Critical signaling events in the mechanoactivation of human mast cells through p.C492Y-ADGRE2, J Investig Dermatol, 140, 2210, 10.1016/j.jid.2020.03.936 · DOI
  32. Boyden, 2016, Vibratory urticaria associated with a missense variant in ADGRE2, N Engl J Med, 374, 656, 10.1056/NEJMoa1500611 · DOI
  33. Cop, 2018, Influence of IL-6, IL-33, and TNF-α on human mast cell activation: lessons from single cell analysis by flow cytometry, Cytometry B Clin Cytom, 94, 405, 10.1002/cyto.b.21547 · DOI
  34. Desai, 2016, IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3, J Allergy Clin Immunol, 137, 1863, 10.1016/j.jaci.2015.09.059 · DOI
  35. Babina, 2004, Comparative cytokine profile of human skin mast cells from two compartments—strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming, J Leukocyte Biol, 75, 244, 10.1189/jlb.0403157 · DOI
  36. Lorentz, 2005, IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos, J Immunol, 174, 6751, 10.4049/jimmunol.174.11.6751 · DOI
  37. Okayama, 2008, FcεRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells, Eur Respir J, 34, 425, 10.1183/09031936.00121008 · DOI · Paper page
  38. Feuser, 2012, Human intestinal mast cells are a potent source of multiple chemokines, Cytokine, 58, 178, 10.1016/j.cyto.2012.01.001 · DOI
  39. Bachelet, 2006, Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a, J Allergy Clin Immunol, 117, 1314, 10.1016/j.jaci.2006.04.031 · DOI
  40. Yu, 2018, Functional inhibitory siglec-6 is upregulated in human colorectal cancer-associated mast cells, Front Immunol, 9, 2138, 10.3389/fimmu.2018.02138 · DOI
  41. Youngblood, 2019, AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice, Int Arch Allergy Immunol, 180, 91, 10.1159/000501637 · DOI
  42. Mizrahi, 2014, Siglec-7 is an inhibitory receptor on human mast cells and basophils, J Allergy Clin Immunol, 134, 230, 10.1016/j.jaci.2014.03.031 · DOI
  43. Dellon, 2020, Anti–siglec-8 antibody for eosinophilic gastritis and duodenitis, N Engl J Med, 383, 1624, 10.1056/NEJMoa2012047 · DOI
  44. Rossi, 2006, Identification of the Syk kinase inhibitor R112 by a human mast cell screen, J Allergy Clin Immunol, 118, 749, 10.1016/j.jaci.2006.05.023 · DOI
  45. Patou, 2011, Syk-kinase inhibition prevents mast cell activation in nasal polyps, Rhinology, 49, 100, 10.4193/Rhino09.147 · DOI
  46. Kato, 2017, JTE-852, a novel spleen tyrosine kinase inhibitor, blocks mediator secretion from mast cells with immunoglobulin E crosslinking, Eur J Pharmacol, 801, 1, 10.1016/j.ejphar.2017.02.048 · DOI
  47. Ramirez Molina, 2019, GSK2646264, a spleen tyrosine kinase inhibitor, attenuates the release of histamine in ex vivo human skin, Br J Pharmacol, 176, 1135, 10.1111/bph.14610 · DOI
  48. Koziol-White, 2016, Inhibition of spleen tyrosine kinase attenuates IgE-mediated airway contraction and mediator release in human precision cut lung slices, Br J Pharmacol, 173, 3080, 10.1111/bph.13550 · DOI
  49. Dickson, 2021, Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: results of a phase 1a/b randomised double-blind placebo-controlled study, Br J Clin Pharmacol, 87, 4797, 10.1111/bcp.14923 · DOI
  50. Meltzer, 2005, An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment, J Allergy Clin Immunol, 115, 791, 10.1016/j.jaci.2005.01.040 · DOI
  51. Guyer, 2006, Mast cell inhibitor R112 is well tolerated and affects prostaglandin D 2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis, Allergy Asthma Proc, 27, 208, 10.2500/aap.2006.27.2861 · DOI
  52. Kawakami, 1994, Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking, Mol Cell Biol, 14, 5108
  53. Iwaki, 2005, Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by Kit, J Biol Chem, 280, 40261, 10.1074/jbc.M506063200 · DOI
  54. Dispenza, 2020, Bruton’s tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis, J Clin Investig, 130, 4759, 10.1172/JCI138448 · DOI
  55. Smiljkovic, 2017, BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils, Allergy, 72, 1666, 10.1111/all.13166 · DOI
  56. MacGlashan, 2011, Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton’s tyrosine kinase, Btk, inhibitor, Int Immunopharmacol, 11, 475, 10.1016/j.intimp.2010.12.018 · DOI
  57. Metz, 2021, Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial, Nat Med, 27, 1961, 10.1038/s41591-021-01537-w · DOI
  58. Gleixner, 2011, KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib, Blood, 118, 1885, 10.1182/blood-2010-06-289959 · DOI
  59. Harrison, 2007, Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506, Br J Pharmacol, 150, 509, 10.1038/sj.bjp.0707002 · DOI
  60. Zuberbier, 2001, The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils, J Allergy Clin Immunol, 108, 275, 10.1067/mai.2001.116865 · DOI
  61. Jin, 2016, Toll-like receptor 2-mediated MAPKs and NF-κB activation requires the GNAO1-dependent pathway in human mast cells, Integr Biol, 8, 968, 10.1039/c6ib00097e · DOI
  62. Sandig, 2012, TLR signaling in mast cells: common and unique features, Front Immunol, 3, 185, 10.3389/fimmu.2012.00185 · DOI
  63. Suurmond, 2015, Differential TLR-induced cytokine production by human mast cells is amplified by FcϵRI triggering, Clin Exp Allergy, 45, 788, 10.1111/cea.12509 · DOI
  64. Tancowny, 2010, Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2, Immunology, 131, 220, 10.1111/j.1365-2567.2010.03296.x · DOI
  65. Wang, 2022, Cytokine stimulation by MRGPRX2 occurs with lower potency than by FcεRI aggregation but with similar dependence on the extracellular signal–regulated kinase 1/2 module in human skin mast cells, J Invest Dermatol, 142, 414, 10.1016/j.jid.2021.07.153 · DOI
  66. West, 2021, Interleukin-33 amplifies human mast cell activities induced by complement anaphylatoxins, Front Immunol, 11, 10.3389/fimmu.2020.615236 · DOI
  67. Franke, 2021, Cytokines stimulated by IL-33 in human skin mast cells: involvement of nf-κb and p38 at distinct levels and potent co-operation with fcεri and mrgprx2, Int J Mol Sci, 22, 3580, 10.3390/ijms22073580 · DOI
  68. Babina, 2019, Yin-yang of IL-33 in human skin mast cells: reduced degranulation, but augmented histamine synthesis through p38 activation, J Investig Dermatol, 139, 1516, 10.1016/j.jid.2019.01.013 · DOI
  69. Wang, 2019, IL-33 and MRGPRX2-triggered activation of human skin mast cells—elimination of receptor expression on chronic exposure, but reinforced degranulation on acute priming, Cells, 8, 341, 10.3390/cells8040341 · DOI
  70. Sumbayev, 2012, Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils, PLoS One, 7, 10.1371/journal.pone.0034259 · DOI
  71. Sumbayev, 2009, Involvement of hypoxia-inducible factor-1 (HiF-1α) in IgE-mediated primary human basophil responses, Eur J Immunol, 39, 3511, 10.1002/eji.200939370 · DOI
  72. Gibbs, 2012, Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage, Int J Biochem Cell Biol, 44, 1739, 10.1016/j.biocel.2012.06.019 · DOI
  73. Lefranҫais, 2014, Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells, Proc Natl Acad Sci U S A, 111, 15502, 10.1073/pnas.1410700111 · DOI
  74. Elishmereni, 2011, Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro, Allergy, 66, 376, 10.1111/j.1398-9995.2010.02494.x · DOI
  75. Elishmereni, 2013, Interacting mast cells and eosinophils acquire an enhanced activation state in vitro, Allergy, 68, 171, 10.1111/all.12059 · DOI
  76. Salazar-Terreros, 2018, Crosstalk between mast cells and eosinophils can contribute to pathophysiology of sickle cell anemia, Blood, 132, 1070, 10.1182/blood-2018-99-119029 · DOI
  77. Martins, 2015, Mast cells in the colon of Trypanosoma cruzi-infected patients: are they involved in the recruitment, survival and/or activation of eosinophils?, Parasitol Res, 114, 1847, 10.1007/s00436-015-4371-9 · DOI
  78. Galdiero, 2017, Bidirectional mast cell-eosinophil interactions in inflammatory disorders and cancer, Front Med, 4, 103, 10.3389/fmed.2017.00103 · DOI
  79. Altrichter, 2020, The role of eosinophils in chronic spontaneous urticaria, J Allergy Clin Immunol, 145, 1510, 10.1016/j.jaci.2020.03.005 · DOI
  80. Lotfi-Emran, 2018, Human mast cells present antigen to autologous CD4+ T cells, J Allergy Clin Immunol, 141, 311, 10.1016/j.jaci.2017.02.048 · DOI
  81. Kambayashi, 2014, Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?, Nat Rev Immunol, 14, 719, 10.1038/nri3754 · DOI
  82. Mion, 2014, Mast cells control the expansion and differentiation of IL-10–competent B cells, J Immunol, 193, 4568, 10.4049/jimmunol.1302593 · DOI
  83. D’Incà, 2015, Exosomes: tiny clues for mast cell communication, Front Immunol, 6, 73
  84. Skokos, 2001, Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes, J Immunol, 166, 868, 10.4049/jimmunol.166.2.868 · DOI
  85. Li, 2016, Mast cell-derived exosomes promote Th2 cell differentiation via OX40L-OX40 ligation, J Immunol Res, 2016, 10.1155/2016/3623898 · DOI
  86. Dudeck, 2011, Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function, Eur J Immunol, 41, 1883, 10.1002/eji.201040994 · DOI
  87. Merluzzi, 2010, Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells, Blood, 115, 2810, 10.1182/blood-2009-10-250126 · DOI
  88. Carroll-Portillo, 2015, Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation, J Cell Biol, 210, 851, 10.1083/jcb.201412074 · DOI
  89. Choi, 2018, Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles, Science, 362, 10.1126/science.aao0666 · DOI
  90. Chéret, 2021, Re-innervation of human skin by rat dorsal root ganglia permits to study interactions between sensory nerve fibres and native human dermal mast cells ex vivo, Exp Dermatol, 30, 418, 10.1111/exd.14245 · DOI
  91. Siiskonen, 2019, Mast cells and sensory nerves contribute to neurogenic inflammation and pruritus in chronic skin inflammation, Front Cell Neurosci, 13, 422, 10.3389/fncel.2019.00422 · DOI
  92. Bagher, 2018, Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2, Cell Commun Signal, 16, 1, 10.1186/s12964-018-0269-3 · DOI
  93. Frungieri, 2002, Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: possible relevance to human fibrotic disorders, Proc Natl Acad Sci U S A, 99, 15072, 10.1073/pnas.232422999 · DOI
  94. Divoux, 2012, Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes, J Clin Endocrinol Metab, 97, E1677, 10.1210/jc.2012-1532 · DOI
  95. Elieh Ali Komi, 2020, Crosstalk between mast cells and adipocytes in physiologic and pathologic conditions, Clin Rev Allergy Immunol, 58, 388, 10.1007/s12016-020-08785-7 · DOI
  96. Finlin, 2019, Adipose tissue mast cells promote human adipose beiging in response to cold, Sci Rep, 9, 1, 10.1038/s41598-019-45136-9 · DOI
  97. Gülen, 2021, Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis, J Allergy Clin Immunol, 148, 889, 10.1016/j.jaci.2021.02.023 · DOI
  98. Schwartz, 1994, Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis, J Clin Immunol, 14, 190, 10.1007/BF01533368 · DOI · Paper page
  99. Vitte, 2021, Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis, J Allergy Clin Immunol Pract, 9, 2994, 10.1016/j.jaip.2021.03.011 · DOI · Paper page
  100. Garvey, 2019, An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions, Allergy, 74, 1872, 10.1111/all.13820 · DOI
  101. Trivedi, 2009, Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations, J Allergy Clin Immunol, 124, 1099, 10.1016/j.jaci.2009.07.026 · DOI
  102. Soto, 2002, Genetic deficiency of human mast cell α-tryptase, Clin Exp Allergy, 32, 1000, 10.1046/j.1365-2222.2002.01416.x · DOI
  103. Caughey, 2016, Mast cell proteases as pharmacological targets, Eur J Pharmacol, 778, 44, 10.1016/j.ejphar.2015.04.045 · DOI
  104. Wenzel, 2021, Severe adult asthmas: integrating clinical features, biology, and therapeutics to improve outcomes, Am J Respir Crit Care Med, 203, 809, 10.1164/rccm.202009-3631CI · DOI
  105. Zhao, 2022, Mast cell chymase affects the functional properties of primary human airway fibroblasts: implications for asthma, J Allergy Clin Immunol, 149, 718, 10.1016/j.jaci.2021.07.020 · DOI
  106. Maun, 2019, An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma, Cell, 179, 417, 10.1016/j.cell.2019.09.009 · DOI
  107. Cahill, 2019, Unique effect of aspirin therapy on biomarkers in aspirin-exacerbated respiratory disease, Am J Respir Crit Care Med, 200, 704, 10.1164/rccm.201809-1755OC · DOI
  108. Mukai, 2018, Mast cells as sources of cytokines, chemokines, and growth factors, Immunol Rev, 282, 121, 10.1111/imr.12634 · DOI
  109. Marshall, 2004, Mast-cell responses to pathogens, Nat Rev Immunol, 4, 787, 10.1038/nri1460 · DOI
  110. Piliponsky, 2019, Mast cells in viral, bacterial, and fungal infection immunity, Int J Mol Sci, 20, 2851, 10.3390/ijms20122851 · DOI
  111. von Köckritz-Blickwede, 2008, Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation, Blood, 111, 3070, 10.1182/blood-2007-07-104018 · DOI
  112. Edelson, 2004, Mast cell-mediated inflammatory responses require the α2β1 integrin, Blood, 103, 2214, 10.1182/blood-2003-08-2978 · DOI
  113. Siebenhaar, 2007, Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent, Am J Pathol, 170, 1910, 10.2353/ajpath.2007.060770 · DOI
  114. Zimmermann, 2019, Mast cells are critical for controlling the bacterial burden and the healing of infected wounds, Proc Natl Acad Sci U S A, 116, 20500, 10.1073/pnas.1908816116 · DOI
  115. Matsui, 2011, Dermal mast cells reduce progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice, J Med Microbiol, 60, 128, 10.1099/jmm.0.020495-0 · DOI
  116. Mezouar, 2019, Mast cell cytonemes as a defense mechanism against Coxiella burnetii, mBio, 10, 10.1128/mBio.02669-18 · DOI
  117. Lv, 2018, Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis, Cell Death Dis, 9, 457, 10.1038/s41419-018-0493-1 · DOI
  118. Velin, 2005, Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model, Gastroenterology, 129, 142, 10.1053/j.gastro.2005.04.010 · DOI
  119. Lu, 2017, The roles of mast cells in parasitic protozoan infections, Front Immunol, 8, 363, 10.3389/fimmu.2017.00363 · DOI
  120. Linnemann, 2020, Limited role of mast cells during infection with the parasitic nematode Litomosoides sigmodontis, PLoS Negl Trop Dis, 14, 1, 10.1371/journal.pntd.0008534 · DOI
  121. Jiao, 2019, The complex role of mast cells in fungal infections, Exp Dermatol, 28, 749, 10.1111/exd.13907 · DOI
  122. Shimokawa, 2017, Mast cells are crucial for induction of group 2 innate lymphoid cells and clearance of helminth infections, Immunity, 46, 863, 10.1016/j.immuni.2017.04.017 · DOI
  123. Rathore, 2020, Protective and pathogenic roles for mast cells during viral infections, Curr Opin Immunol, 66, 74, 10.1016/j.coi.2020.05.003 · DOI
  124. Sundstrom, 2007, Human tissue mast cells are an inducible reservoir of persistent HIV infection, Blood, 109, 5293, 10.1182/blood-2006-11-058438 · DOI
  125. Afrin, 2020, Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome, Int J Infect Dis, 100, 327, 10.1016/j.ijid.2020.09.016 · DOI
  126. Motta Junior, 2020, Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis, Front Immunol, 11, 10.3389/fimmu.2020.574862 · DOI
  127. Valent, 2020, Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: expert opinions, J Allergy Clin Immunol, 146, 300, 10.1016/j.jaci.2020.06.009 · DOI
  128. Giannetti, 2021, COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms, J Allergy Clin Immunol Pract, 9, 2083, 10.1016/j.jaip.2021.02.023 · DOI

Cited by

Sorted by citations

See all 51

Metadata

Authors
Levi-Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., & Maurer, M.
ORCID
Levi-Schaffer, Francesca
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2022-06
Volume
149
Issue
6
Pages
1833-1844
ISSN
0091-6749
DOI
10.1016/j.jaci.2022.01.030
Cited by
51
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review